ACE2 News and Research

RSS
Community immunity: Steering the evolutionary course of SARS-CoV-2

Community immunity: Steering the evolutionary course of SARS-CoV-2

Engineered bacteria could offer new treatment for hypertension

Engineered bacteria could offer new treatment for hypertension

Is COVID-19 a risk factor for Alzheimer's disease?

Is COVID-19 a risk factor for Alzheimer's disease?

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

Low serotonin levels observed in long COVID and other viral infections

Low serotonin levels observed in long COVID and other viral infections

Green, matcha, and black tea: Effective weapons against Omicron subvariants, research reveals

Green, matcha, and black tea: Effective weapons against Omicron subvariants, research reveals

Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice tests

Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice tests

The power of nanobodies: How they impact COVID-19 immune response

The power of nanobodies: How they impact COVID-19 immune response

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants

Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants

Eris sublineage EG.5.1 can escape neutralizing antibodies better than other SARS-CoV-2 lineages

Eris sublineage EG.5.1 can escape neutralizing antibodies better than other SARS-CoV-2 lineages

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Can SARS-CoV-2 infect poultry?

Can SARS-CoV-2 infect poultry?

SARS-CoV-2 Eris variant spreads faster and dodges immunity

SARS-CoV-2 Eris variant spreads faster and dodges immunity

Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines

Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines

Study investigates the pathophysiological mechanisms of PASC after COVID-19

Study investigates the pathophysiological mechanisms of PASC after COVID-19

Engineered ACE2 decoy shows promise as COVID-19 treatment

Engineered ACE2 decoy shows promise as COVID-19 treatment

Unlocking ACE2: The enzyme that links COVID-19, heart disease, and diabetes

Unlocking ACE2: The enzyme that links COVID-19, heart disease, and diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.